Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GFPT1 | Q06210 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.41 |
| ▸ | GGT1 | P19440 | 4/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.39 |
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | CASR | P41180 | 1/20 | 0.38 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.38 |
| ▸ | GRM6 | O15303 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
| ▸ | GSR | P00390 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL393844 | 1.00 | GFPT1 (0.46) | GFPT1ALOX15BLMPMP22KMT2A | |
| SCHEMBL1527344 | 1.00 | GFPT1 (0.46) | GFPT1ALOX15BLMPMP22KMT2A | |
| Hydrochloric Acid SCHEMBL503105 | 0.98 | GFPT1 (0.44) | GFPT1ALOX15BLMPMP22KMT2A | |
| Hydrochloric Acid SCHEMBL17239121 | 0.98 | GFPT1 (0.44) | GFPT1ALOX15BLMPMP22KMT2A | |
| Adipic Acid SCHEMBL8055763 | 0.89 | BHMT (0.45) | GFPT1ALOX15BLMPMP22KMT2A | |
| SCHEMBL19371887 | 0.84 | GFPT1 (0.32) | GFPT1 | |
| SCHEMBL22122969 | 0.84 | GFPT1 (0.32) | GFPT1 | |
| SCHEMBL27644228 | 0.84 | SLC7A5 (0.42) | ALOX15BLMPMP22KMT2APTGS1 | |
| SCHEMBL27644223 | 0.84 | SLC7A5 (0.42) | ALOX15BLMPMP22KMT2APTGS1 | |
| SCHEMBL1478033 | 0.82 | SLC7A5 (0.41) | ALOX15BLMPMP22KMT2APTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 319 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250208137-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2025-06-26 | — | — | US | claimed |
| WO-2025094120-A1 | CATIONIC PEPTIDES WITH BROAD SPECTRUM ACTIVITY | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2025-05-08 | — | — | WO | claimed |
| EP-4493273-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | Politechnika Wroclawska (PL) | 2025-01-22 | — | — | EP | claimed |
| WO-2023175356-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | POLITECHNIKA WROCLAWSKA (PL) | 2023-09-21 | — | — | WO | claimed |
| US-20220372022-A1 | COMPOUNDS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS | FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) | 2022-11-24 | — | — | US | claimed |
| CN-115246872-A | Conotoxin mutant and preparation method and application thereof | 中国海洋大学 | 2022-10-28 | — | — | CN | claimed |
| WO-2019179985-A1 | INHIBITORS OF MINT AND USES THEREOF | UNIVERSITY OF COPENHAGEN (DK) | 2019-09-26 | — | — | WO | claimed |
| US-20260146063-A1 | CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260115301-A1 | INTRACELLULAR DELIVERY OF NUCLEIC ACIDS | OHIO STATE INNOVATION FOUNDATION (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4717776-A2 | POLYPEPTIDE CONJUGATES FOR INTRACELLULAR DELIVERY OF NUCLEIC ACIDS | Ohio State Innovation Foundation (US) | 2026-04-01 | — | — | EP | disclosed |
| US-12589088-B2 | Compositions and methods for treating cancer with andrographolide and melatonin combination therapy | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2026-03-31 | — | — | US | disclosed |
| US-20260083852-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | UNIV CALIFORNIA (US) | 2026-03-26 | — | — | US | disclosed |
| EP-4706689-A2 | COMPOSITIONS FOR DELIVERY OF ANTISENSE COMPOUNDS | Entrada Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20050136017-A1 | Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin | L'OREAL S.A. (FR) | 2005-06-23 | — | — | US | disclosed |
| US-20050129645-A1 | Hair shaping composition comprising at least one non-hydroxide imine | L'OREAL | 2005-06-16 | — | — | US | disclosed |
| EP-1532963-A1 | Composition for straightening the hair comprising at least one imine not being an hydroxide | L'OREAL (FR) | 2005-05-25 | — | — | EP | disclosed |
| EP-1532960-A1 | Hair styling composition containing a non-hydroxide imine | L'OREAL (FR) | 2005-05-25 | — | — | EP | disclosed |
| EP-1390003-A1 | COMPOSITION AND METHODS FOR LANTHIONIZING KERATIN FIBERS USING AT LEAST ONE ORGANIC NUCLEOPHILE AND AT LEAST ONE HYDROXIDE ION GENERATOR | L'OREAL S.A. (FR) | 2004-02-25 | — | — | EP | disclosed |
| US-20020189027-A1 | Composition and methods for lanthionizing keratin fibers using at least one organic nucleophile and at least one hydroxide ion generator | L'OREAL S.A. (FR) | 2002-12-19 | — | — | US | disclosed |
| WO-2002085317-A1 | COMPOSITION AND METHODS FOR LANTHIONIZING KERATIN FIBERS USING AT LEAST ONE ORGANIC NUCLEOPHILE AND AT LEAST ONE HYDROXIDE ION GENERATOR | L'OREAL S.A. (FR) | 2002-10-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115301-A1 | INTRACELLULAR DELIVERY OF NUCLEIC ACIDS | SLC7A1, SRM, SLC6A19 | GFPT1 653/4885ALOX15 4812/4885BLM 2170/4885 |
| US-12589088-B2 | Compositions and methods for treating cancer with andrographolide and melatonin combination therapy | MTNR1A, CYP27A1, CRY2 | GFPT1 1104/4885ALOX15 877/4885BLM 2981/4885 |
| US-20260146063-A1 | CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF | VIP, SLC7A1, SLC6A15 | GFPT1 904/4885ALOX15 4408/4885BLM 3835/4885 |
| US-20220372022-A1 | COMPOUNDS FOR USE IN SYNTHESIS OF PEPTIDOMIMETICS | DNPEP, NPEPPS, PAM | GFPT1 213/4885ALOX15 3961/4885BLM 3782/4885 |
| US-20250208137-A1 | COMPOUNDS FOR THE DETECTION AND INHIBITION OF COAGULATION PROTEASES | F11, F2, F12 | GFPT1 3221/4885ALOX15 1843/4885BLM 3997/4885 |
| US-20050129645-A1 | Hair shaping composition comprising at least one non-hydroxide imine | KRT18, INHA, H1-5 | GFPT1 4730/4885ALOX15 4080/4885BLM 534/4885 |
| US-20260083852-A1 | PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR | PDGFA, DCLRE1A, PDGFRA | GFPT1 4159/4885ALOX15 4509/4885BLM 820/4885 |
| US-20050136017-A1 | Cosmetic containing an imine reactive with the cystines of keratin fibers via a beta-elimination reaction to produce dehydroalanine and lead to formation of lanthionine in a medium free of polyhydroxylated alkane; guanidine and/or amidine imines such as dimethylguanidine; noncaustic for use on hair, skin | BHMT, KRT18, INMT | GFPT1 2002/4885ALOX15 2498/4885BLM 767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.